Back to Search
Start Over
Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
- Source :
- Journal of surgical oncology. 109(5)
- Publication Year :
- 2013
-
Abstract
- To determine the role of surgery in complete responders on FDG-PET after CRT and the prognostic significance of metabolic response in locally advanced esophageal squamous cell carcinoma.We retrospectively reviewed 154 patients with locally advanced esophageal cancer with increased uptake on FDG-PET. Eighty-one patients received definitive CRT and 73 received trimodality therapy. We defined metabolic complete remission (PET-CR) when FDG uptake of the primary tumor and lymph nodes were decreased and was indistinguishable from surrounding normal tissue. Oncologic outcomes were compared between trimodality group, definitive CRT group, and PET-CR subgroup of definitive CRT.Thirty-one (38.3%) of the definitive CRT patients and 39 (53.4%) of the trimodality therapy patients achieved PET-CR after CRT. The 2-year OS of the trimodality group was higher than that of the definitive CRT group, but equivalent to that of the PET-CR subgroup of definitive CRT. The 2-year LRFS and DFS of the trimodality group were higher than that of the PET-CR subgroup or the entire of definitive CRT group.The addition of surgery showed higher DFS and LRFS rates than those of the PET-CR subgroup of definitive CRT. Despite achieving PET-CR, surgery still seems to improve local tumor control.
- Subjects :
- Adult
Aged, 80 and over
Male
Esophageal Neoplasms
Remission Induction
Chemoradiotherapy
Middle Aged
Prognosis
Neoadjuvant Therapy
Esophagectomy
Treatment Outcome
Fluorodeoxyglucose F18
Predictive Value of Tests
Positron-Emission Tomography
Carcinoma, Squamous Cell
Odds Ratio
Humans
Female
Treatment Failure
Radiopharmaceuticals
Aged
Neoplasm Staging
Retrospective Studies
Subjects
Details
- ISSN :
- 10969098
- Volume :
- 109
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Journal of surgical oncology
- Accession number :
- edsair.pmid..........60dc37f7e5c4dc230ce9fd07a83178c5